Binkui Li
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in ⓘ
- Hepatology 57
- Hepatocellular Carcinoma Treatment and Prognosis 55
-
- Cancer, Lipids, and Metabolism 9
- MicroRNA in disease regulation 9
- Co-authors
- Yunfei Yuan (82 shared papers)Yun Zheng (38 shared papers)Jiliang Qiu (42 shared papers)Wei He (39 shared papers)Pinzhu Huang (15 shared papers)Ruhai Zou (27 shared papers)Jian Hong (15 shared papers)Xin‐Yuan Guan (10 shared papers)
- Journals
- BMC Cancer (6 papers)Journal of Cancer (5 papers)Cancer Communications (3 papers)Oncogene (3 papers)Annals of Translational Medicine (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Binkui Li
99 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Hepatology 932
- Cancer Research 950
- Oncology 743
- Molecular Biology 1.3k
- Pathology and Forensic Medicine 296
Countries citing papers authored by Binkui Li
This map shows the geographic impact of Binkui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binkui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binkui Li more than expected).
Fields of papers citing papers by Binkui Li
This network shows the impact of papers produced by Binkui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binkui Li. The network helps show where Binkui Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Binkui Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 173 | |
| 2 | 2017 | 122 | |
| 3 | 2017 | 106 | |
| 4 | 2009 | 96 | |
| 5 | 2012 | 96 | |
| 6 | 2015 | 93 | |
| 7 | 2013 | 88 | |
| 8 | 2010 | 79 | |
| 9 | 2009 | 78 | |
| 10 | 2012 | 76 | |
| 11 | 2018 | 72 | |
| 12 | TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study Hit paper breakdown → | 2023 | 71 |
| 13 | 2011 | 70 | |
| 14 | 2020 | 66 | |
| 15 | 2017 | 60 | |
| 16 | 2013 | 59 | |
| 17 | 2011 | 57 | |
| 18 | 2022 | 53 | |
| 19 | 2021 | 53 | |
| 20 | 2009 | 52 |
About Binkui Li
Binkui Li is a scholar working on Hepatology, Cancer Research, Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 103 papers that have together received 2.8k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (55 papers), Liver Disease Diagnosis and Treatment (22 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (22 papers), Cancer Mechanisms and Therapy (12 papers), RNA modifications and cancer (11 papers), Colorectal Cancer Treatments and Studies (10 papers), Cancer, Lipids, and Metabolism (9 papers) and MicroRNA in disease regulation (9 papers). The work is most often cited by research in Hepatology (932 citations), Cancer Research (950 citations), Oncology (743 citations), Molecular Biology (1.3k citations) and Pathology and Forensic Medicine (296 citations). Binkui Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yunfei Yuan, Yun Zheng, Jiliang Qiu, Wei He, Pinzhu Huang, Ruhai Zou, Jian Hong, Xin‐Yuan Guan, Dan Xie and Yuanping Zhang. Their work appears in journals such as BMC Cancer, Journal of Cancer, Cancer Communications, Oncogene and Annals of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.